Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone/salmeterol effect on bone density in COPD
NCT00355342Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2004
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Apr 2004; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00355342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355342.